Gene signatures associated with mouse postnatal hindbrain neural stem cells and medulloblastoma cancer stem cells identify novel molecular mediators and predict human medulloblastoma molecular classification

Cancer Discovery

Volumn 2, Issue 6, 2012, Pages 554-568

  Corno, Daniela ^a   Pala, Mauro ^e   Cominelli, Manuela ^f   Cipelletti, Barbara ^a   Leto, Ketty ^g   Croci, Laura ^c   Barili, Valeria ^c   Brandalise, Federico ^h   Melzi, Raffaella ^d   Di Gregorio, Alessandra ^g   Sergi, Lucia Sergi ^b   Politi, Letterio Salvatore ^d   Piemonti, Lorenzo ^d   Bulfone, Alessandro ^e   Rossi, Paola ^h   Rossi, Ferdinando ^g   Consalez, Gian Giacomo ^c   Poliani, Pietro Luigi ^f   Galli, Rossella ^a  

^a Neural Stem Cell Biology Unit   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c Division of Neuroscience   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e Bio))flag Ltd   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EARLY B CELL FACTOR 2; POTASSIUM ION; PROTEIN P53; PROTEIN PATCHED; SODIUM ION; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EMX2; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FOURTH VENTRICLE; CANCER STEM CELL; CARCINOGENICITY; CEREBELLUM TUMOR; CLASSIFICATION; CONTROLLED STUDY; CYTOLOGY; FEMALE; FLOW CYTOMETRY; FOREBRAIN; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; GENETICS; GROWTH CURVE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ION CURRENT; MEDULLOBLASTOMA; METABOLISM; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEWBORN; NONHUMAN; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHOMBENCEPHALON; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; CEREBELLAR NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; MEDULLOBLASTOMA; MICE; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; RHOMBENCEPHALON;

EID: 84866335047     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-11-0199     Document Type: Article

References (38)

1. Carletti B, Rossi F. Neurogenesis in the cerebellum. Neuroscientist 2008;14:91-100.
2. Gulino A, Arcella A, Giangaspero F. Pathological and molecular heterogeneity of medulloblastoma. Curr Opin Oncol 2008;20:668-75.
3. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 2010;468:1095-9.
4. Klein C, Butt SJ, Machold RP, Johnson JE, Fishell G. Cerebellumand forebrain-derived stem cells possess intrinsic regional character. Development 2005;132:4497-508.
5. Lee A, Kessler JD, Read TA, Kaiser C, Corbeil D, Huttner WB, et al. Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci 2005;8:723-9.
6. Sutter R, Shakhova O, Bhagat H, Behesti H, Sutter C, Penkar S, et al. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene 2010;29:1845-56.
7. Weiss S, Dunne C, Hewson J, Wohl C, Wheatley M, Peterson AC, et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 1996;16:7599-609.
8. Golmohammadi MG, Blackmore DG, Large B, Azari H, Esfandiary E, Paxinos G, et al. Comparative analysis of the frequency and distribution of stem and progenitor cells in the adult mouse brain. Stem Cells 2008;26:979-87.
9. Ward RJ, Lee L, Graham K, Satkunendran T, Yoshikawa K, Ling E, et al. Multipotent CD15eecancer stem cells in patched-1-deficient mouse medulloblastoma. Cancer Res 2009;69:4682-90.
10. Wetmore C, Eberhart DE, Curran T. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res 2001;61:513-6.
11. Read TA, Fogarty MP, Markant SL, McLendon RE, Wei Z, Ellison DW, et al. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell 2009;15:135-47.
12. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010;140:62-73.
13. Merlos-Suarez A, Barriga FM, Jung P, Iglesias M, Céspedes MV, Rossell D, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011;8:511-24.
14. Martens DJ, Seaberg RM, van der Kooy D. In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord. Eur J Neurosci 2002;16:1045-57.
15. Melzi R, Antonioli B, Mercalli A, Battaglia M, Valle A, Pluchino S, et al. Co-graft of allogeneic immune regulatory neural stem cells (NPC) and pancreatic islets mediates tolerance, while inducing NPCderived tumors in mice. PLoS One 2010;5:e10357.
16. Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011;29:1408-14.
17. Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, et al. Hypoxiainducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009;15:501-13.
18. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-21.
19. Kieslinger M, Hiechinger S, Dobreva G, Consalez GG, Grosschedl R. Early B cell factor 2 regulates hematopoietic stem cell homeostasis in a cell-nonautonomous manner. Cell Stem Cell 2010;7:496-507.
20. Hatten ME, Roussel MF. Development and cancer of the cerebellum. Trends Neurosci 2011;34:134-42.
21. Leto K, Carletti B, Williams IM, Magrassi L, Rossi F. Different types of cerebellar GABAergic interneurons originate from a common pool of multipotent progenitor cells. J Neurosci 2006;26:11682-94.
22. Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Ann Rev Neurosci 2001;24:385-428.
23. Hitoshi S, Tropepe V, Ekker M, van der Kooy D. Neural stem cell lineages are regionally specified, but not committed, within distinct compartments of the developing brain. Development 2002;129:233-44.
24. Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 2008;3:e3088.
25. Sasai K, Romer JT, Lee Y, Finkelstein D, Fuller C, McKinnon PJ, et al. Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies. Cancer Res 2006;66:4215-22.
26. Chatel G, Ganeff C, Boussif N, Delacroix L, Briquet A, Nolens G, et al. Hedgehog signaling pathway is inactive in colorectal cancer cell lines. Int J Cancer 2007;121:2622-7.
27. Palma V, Lim DA, Dahmane N, Sánchez P, Brionne TC, Herzberg CD, et al. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 2005;132:335-44.
28. Po A, Ferretti E, Miele E, De Smaele E, Paganelli A, Canettieri G, et al. Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO J 2010;29:2646-58.
29. Zbinden M, Duquet A, Lorente-Trigos A, Ngwabyt SN, Borges I, Ruiz i Altaba A. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 2010;29:2659-74.
30. Reynolds BA, Rietze RL. Neural stem cells and neurospheres-re-evaluating the relationship. Nat Methods 2005;2:333-6.
31. Fogarty MP, Emmenegger BA, Grasfeder LL, Oliver TG, Wechsler-Reya RJ. Fibroblast growth factor blocks Sonic hedgehog signaling in neuronal precursors and tumor cells. Proc Natl Acad Sci U S A 2007;104:2973-8.
32. Schuller U, Heine VM, Mao J, Kho AT, Dillon AK, Han YG, et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008;14:123-34.
33. Yang ZJ, Ellis T, Markant SL, Read TA, Kessler JD, Bourboulas M, et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008;14:135-45.
34. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997;277:1109-13.
35. Pfaff E, Remke M, Sturm D, Benner A, Witt H, Milde T, et al. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol 2010;28:5188-96.
36. Garel S, Marin F, Mattei MG, Vesque C, Vincent A, Charnay P. Family of EbfoOlf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system. Dev Dyn 1997;210:191-205.
37. Zhao LY, Niu Y, Santiago A, Liu J, Albert SH, Robertson KD, et al. An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis. Cancer Res 2006;66:9445-52.
38. Galli R, Fiocco R, De Filippis L, Muzio L, Gritti A, Mercurio S, et al. Emx2 regulates the proliferation of stem cells of the adult mammalian central nervous system. Development 2002;129:1633-44.